SHIONOGI & CO
4507.T
¥ 6,800.00
0.66%
Marketcap
2.04T
Volume
¥ 1,406,300.00
Shares
299,732,000
Range
¥ 6,789.00 – ¥ 6,838.00
52 Week Range
¥ 6,105.00 – ¥ 8,350.00

More Info for SHIONOGI & CO (4507.T)

  • Charts
  • Brokers

  • Description

  • News

  • Comments

Stocks Brokers
Get:
Social
Trading Platform
Follow and Copy the Best Trader on the Largest Social Trading Platform.
4.3 rating
4.3
‏Disclaimer
New customers only

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider.

Join more than
1 million
clients that place their trust
One of 160 largest listed companies in Germany.
3.0 rating
3.0
Disclaimer
New customers only

Investing can be rewarding but it is not without risk. You can lose your deposit. At DEGIRO, we are open and transparent about the risks that come with investing. Before you start to invest, there are a number of factors to consider. You can read more about the risks of investing in our Investors Services Information documents or our dedicated risk page.

Get up to:
50% lower than the industry
Earn extra income on your lendable shares
Free Trading Tools
2.0 rating
2.0
Disclaimer
New customers only

Warning: Your capital is at risk and your losses may exceed the value of your original investment.

Is authorised and regulated by the Financial Conduct Authority. FCA register entry number 208159.
SHIONOGI & CO
Symbol: 4507.T
Employees: 5693
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-117957 for Insomnia; sivopixant for Neuropathic pain, Sleep Apnea Syndrome, and Refractory/unexplainedchronic cough; S-637880 for Neuropathic Low Back Pain; Zuranolone for Depression; SDT-001 for attention-deficit/hyperactivity disorder patients; BPN14770 for Fragile X syndrome and Alzheimer’s disease; and S-237648 and S-309309 for Obesity. In addition, the company develops ADR-001 for Decompensated liver cirrhosis; S-723595 for NASH; S-588410 for Esophageal and Bladder cancer; S-488210 for Head and neck squamouscell carcinoma; S-588210 for Solid tumor; S-222611 for Malignant tumor; S-770108 for Idiopathic pulmonary fibrosis; SR-0379 for Cutaneous ulcer; S-005151 for Stroke and Epidermolysis bullosa; S-531011 for Solid tumor; S-0373 for Spinocerebellar ataxia; and S-600918 and S-217622 for COVID-19, as well as S-555739 for Control of the aggravation of COVID-19. Further, it offers antibody test kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with Nagasaki University, the National Institute of Infectious Diseases, and The Kitasato University to develop antimalarial drugs. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.
JPX
Healthcare
Drug Manufacturers—Specialty & Generic
1-8, Doshomachi 3-chome, Osaka, Japan
Japan

How to invest on SHIONOGI & CO?

To invest or trade stocks SHIONOGI & CO you need a broker to execute your positions.
But before directing you to a broker compatible with your needs, I would like to give you a Stock Summary on SHIONOGI & CO.

SHIONOGI & CO(4507.T) stock market review

The company SHIONOGI & CO based in Japan, is specialized in the Drug Manufacturers—Specialty & Generic industry, the Healthcare sector and employs more than 5,693 employees.

The SHIONOGI & CO (4507.T) share price is currently ¥ 6,800.00 with 299,732,000 shares outstanding, representing a market cap of ¥ 2,038,177,595,392.00. The daily volume is 1,406,300 and the previous close of the share value was ¥ 6,845.00.
Over the past 52 weeks, the stock has traded low at ¥ 6,105.00 and high at ¥ 8,350.00.
SHIONOGI & CO offers earnings per share of 392.6.
Regarding dividends, the dividend yield for SHIONOGI & CO is 1.7531045 and the dividend rate is 120.

Choose a Broker to trade on SHIONOGI & CO

There are several things to check before taking your first steps with your new broker. This is the reason why at AdonFinance we find the broker that suits you. To view the article on how to choose a broker, go to the site menu, and click on Brokers.

To choose a broker who offers the possibility of trading on the SHIONOGI & CO (4507.T ) share, click on the button below:

Find Brokers for SHIONOGI & CO (4507.T)

Get:
Social
Trading Platform
Follow and Copy the Best Trader on the Largest Social Trading Platform.
4.3 rating
4.3
‏Disclaimer
New customers only

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider.

Join more than
1 million
clients that place their trust
One of 160 largest listed companies in Germany.
3.0 rating
3.0
Disclaimer
New customers only

Investing can be rewarding but it is not without risk. You can lose your deposit. At DEGIRO, we are open and transparent about the risks that come with investing. Before you start to invest, there are a number of factors to consider. You can read more about the risks of investing in our Investors Services Information documents or our dedicated risk page.

Get up to:
50% lower than the industry
Earn extra income on your lendable shares
Free Trading Tools
2.0 rating
2.0
Disclaimer
New customers only

Warning: Your capital is at risk and your losses may exceed the value of your original investment.

Is authorised and regulated by the Financial Conduct Authority. FCA register entry number 208159.

Leave a Reply

Your email address will not be published. Required fields are marked *

AdonFinance
Risk Warning: The material on this website is provided for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation or endorsement for any security or strategy, nor does it constitute an offer to provide investment advisory or other services by AdonFinance. In addition, the content of the website offers no opinion with respect to the suitability of any security or any specific investment. Trading foreign exchange, stocks, cryptocurrencies and commodities is potentially high risk and may not be suitable for all investors. The high level of leverage can work both for and against traders. Before any investment with any broker you need to carefully consider your targets, previous experience, and risk level. Forex trading can result in the loss of your money, as a result, you are expressly cautioned that you should never invest or trade with money that you cannot afford to lose. For the avoidance of doubt, AdonFinance's service provides Brokers reviews in the Financial market. AdonFinance, its subsidiaries, agents or affiliates will assume no responsibility whatsoever for your trading activity. © Copyright 2021 AdonFinance